Literature DB >> 29722

Characterization of the principal human prostatic acid phosphatase isoenzyme, purified by affinity chromatography and isoelectric focusing. Part II.

P Vihko.   

Abstract

The principal enzyme of human prostatic acid phosphatase [orthophosphoric monoester phosphohydrolase (acid optimum), EC 3.1.3.2], which had been highly purified by affinity chromatography, isoelectric focusing, and gel filtrations, was shown to be homogeneous at pH 5.0 by sedimentation equilibrium analysis. The amino acid composition was determined and the sedimentation coefficient of the native molecule measured. The relative molecular mass was 89,000 at pH 5.0, as measured by analytical ultracentrifugation. The Km-value of the enzyme for p-nitrophenyl phosphate as substrate is 1.8-10(-4) mol/liter. I also examined substrate speificity, different inhibitors, and the effects of pH, temperature, and serum on the enzyme activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 29722

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  10 in total

1.  Prostatic acid phosphatase reduces thermal sensitivity and chronic pain sensitization by depleting phosphatidylinositol 4,5-bisphosphate.

Authors:  Nathaniel A Sowa; Sarah E Street; Pirkko Vihko; Mark J Zylka
Journal:  J Neurosci       Date:  2010-08-04       Impact factor: 6.167

2.  Ecto-5'-nucleotidase (CD73) inhibits nociception by hydrolyzing AMP to adenosine in nociceptive circuits.

Authors:  Nathaniel A Sowa; Bonnie Taylor-Blake; Mark J Zylka
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

3.  Effect of Fe2+ and ascorbic acid on acid phosphatases from rat bone.

Authors:  T R Anderson; S U Toverud
Journal:  Calcif Tissue Int       Date:  1982-01       Impact factor: 4.333

4.  Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine.

Authors:  Mark J Zylka; Nathaniel A Sowa; Bonnie Taylor-Blake; Margaret A Twomey; Annakaisa Herrala; Vootele Voikar; Pirkko Vihko
Journal:  Neuron       Date:  2008-10-09       Impact factor: 17.173

Review 5.  Human prostatic acid phosphatase: structure, function and regulation.

Authors:  Sakthivel Muniyan; Nagendra K Chaturvedi; Jennifer G Dwyer; Chad A Lagrange; William G Chaney; Ming-Fong Lin
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

6.  Complex coordinated extracellular metabolism: Acid phosphatases activate diluted human leukocyte proteins to generate energy flow as NADPH from purine nucleotide ribose.

Authors:  John B Hibbs; Zdenek Vavrin; James E Cox
Journal:  Redox Biol       Date:  2016-02-02       Impact factor: 11.799

7.  Recombinant mouse PAP has pH-dependent ectonucleotidase activity and acts through A(1)-adenosine receptors to mediate antinociception.

Authors:  Nathaniel A Sowa; Kunjumon I Vadakkan; Mark J Zylka
Journal:  PLoS One       Date:  2009-01-22       Impact factor: 3.240

8.  Prostate Secretory Protein of 94 amino acids (PSP94) binds to prostatic acid phosphatase (PAP) in human seminal plasma.

Authors:  Jenifer H Anklesaria; Dhanashree D Jagtap; Bhakti R Pathak; Kaushiki M Kadam; Shaini Joseph; Smita D Mahale
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

9.  Transmembrane prostatic acid phosphatase (TMPAP) interacts with snapin and deficient mice develop prostate adenocarcinoma.

Authors:  Ileana B Quintero; Annakaisa M Herrala; César L Araujo; Anitta E Pulkka; Sampsa Hautaniemi; Kristian Ovaska; Evgeny Pryazhnikov; Evgeny Kulesskiy; Maija K Ruuth; Ylermi Soini; Raija T Sormunen; Leonard Khirug; Pirkko T Vihko
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

10.  Consequences of the lack of CD73 and prostatic acid phosphatase in the lymphoid organs.

Authors:  Gennady G Yegutkin; Kaisa Auvinen; Marika Karikoski; Pia Rantakari; Heidi Gerke; Kati Elima; Mikael Maksimow; Ileana B Quintero; Pirkko Vihko; Marko Salmi; Sirpa Jalkanen
Journal:  Mediators Inflamm       Date:  2014-08-24       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.